Intraductal carcinoma in situ of unspecified breast
ICD-10 D05.10 is a billable code used to indicate a diagnosis of intraductal carcinoma in situ of unspecified breast.
Intraductal carcinoma in situ (DCIS) of the breast is a non-invasive form of breast cancer characterized by the presence of abnormal cells within the ducts of the breast tissue. These cells have not invaded surrounding breast tissue, which differentiates DCIS from invasive breast cancer. The condition is often detected through mammography, where microcalcifications may be noted. DCIS is considered a precursor to invasive breast cancer, and while it is not life-threatening in itself, it poses a significant risk for progression to invasive disease if left untreated. Treatment options typically include lumpectomy, mastectomy, and radiation therapy, depending on the extent of the disease and patient preferences. Surveillance protocols for patients diagnosed with DCIS often involve regular mammograms and clinical breast exams to monitor for any signs of progression. The risk of progression to invasive breast cancer varies based on factors such as the grade of the DCIS, the presence of comedonecrosis, and the patient's age and family history. Understanding these factors is crucial for determining the appropriate management and follow-up care.
Detailed pathology reports, treatment plans, and follow-up care notes.
Diagnosis of DCIS following a mammogram, treatment planning for lumpectomy or mastectomy.
Ensure accurate staging and grading of DCIS to guide treatment and follow-up.
Clear imaging reports indicating findings of microcalcifications or other abnormalities.
Mammography findings leading to biopsy and diagnosis of DCIS.
Documentation must correlate imaging findings with pathology results.
Used when a patient with DCIS undergoes a lumpectomy.
Operative report detailing the procedure and findings.
Oncology specialists must ensure accurate coding based on the surgical approach.
DCIS is a non-invasive condition where abnormal cells are confined to the ducts of the breast, while invasive breast cancer has spread beyond the ducts into surrounding tissue.
